AbCellera Biologics Inc. (ABCL)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Carl Lars G. Hansen
Employees:
500
2215 YUKON STREET, VANCOUVER, CANADA V5Y 0A1
(604) 559-9005

AbCellera Biologics Inc. has 156 discovery programs that are either completed, in progress, or under contract with 36 partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Data derived from most recent annual or quarterly report
Market Cap 1.383 Billion Shares Outstanding289.356 Million Avg 30-day Volume 1.492 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0.09
Price to Revenue26.4276 Debt to Equity0.0456 EBITDA-188.86 Million
Price to Book Value1.1259 Operating Margin-414.62789999999995 Enterprise Value511.887 Million
Current Ratio8.341 EPS Growth-1.563 Quick Ratio7.468
1 Yr BETA 1.2134 52-week High/Low 14.0 / 3.87 Profit Margin-256.283
Operating Cash Flow Growth-97.1071 Free Cash Flow to Firm (FCFF) TTM -186.45 Million Free Cash Flow to Equity (FCFE) TTM-213.109 Million
Altman Z-Score2.9518
Earnings Report2024-02-20

Are you looking for this stock instead?

View SEC Filings from ABCL instead.

View recent insider trading info

AbCellera Biologics Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ABCL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABCL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-27 by HANSEN CARL L. G.
  • 4: filed on 2023-11-08 by MONTALBANO JOHN S.
  • 4: filed on 2023-09-14 by LECAULT VERONIQUE
  • 4: filed on 2023-08-25 by HANSEN CARL L. G.
  • 4: filed on 2023-05-30 by HANSEN CARL L. G.
  • 4: filed on 2023-05-26 by BOOTH ANDREW
  • 4: filed on 2023-05-26 by THERMOPYLAE HOLDINGS LTD.
  • 4: filed on 2023-05-09 by LECAULT VERONIQUE
  • 4: filed on 2023-02-23 by HANSEN CARL L. G.
  • 4: filed on 2022-12-22 by BOOTH ANDREW

    • Events (8k)

  • 8-K: filed on 2023-11-28:
    Item 8.01: Other Events
  • 8-K: filed on 2023-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-13:
    Item 8.01: Other Events
  • 8-K: filed on 2023-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-20:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-13:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-02-21:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    30 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    56.1 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HANSEN CARL L. G. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    • 10% Owner
    		 56,685,993 2023-11-23 5

    MONTALBANO JOHN S.

    • Director
    		 167,000 2023-11-06 2

    HAYDEN MICHAEL R

    • Director
    		 1,441,642 2023-09-22 3

    LECAULT VERONIQUE CHIEF OPERATING OFFICER

    • Officer
    • Director
    		 9,530,340 2023-09-12 3

    BOOTH ANDREW CHIEF FINANCIAL OFFICER

    • Officer
    		 283,959 2023-05-26 3

    THERMOPYLAE HOLDINGS LTD.

    • 10% Owner
    		 56,012,493 2023-05-26 2

    LO ANDREW

    • Director
    		 138,556 2022-12-01 1

    STIMART TRYN CHIEF LEGAL OFFICER

    • Officer
    		 2,658,381 2022-12-01 1

    FALCONER ESTER CHIEF TECHNOLOGY OFFICER

    • Officer
    		 0 2021-09-23 0

    HAMER JOHN

    • Director
    		 14,734,623 2021-08-31 0

    DCVC BIO, L.P.

    DCVC BIO GP, LLC

    JNK CAPITAL MANAGEMENT, LLC

    ZNM CAPITAL MANAGEMENT, LLC

    BOGUE ZACHARY

    OCKO MATTHEW

    STEAD KIERSTEN

    • 10% Owner
    		 24,179,653 2021-06-18 0

    THIEL PETER

    • Director
    		 14,360,427 2020-12-15 0

    DCVC BIO, L.P.

    DCVC BIO GP, LLC

    ZNM CAPITAL MANAGEMENT, LLC

    OCKO MATTHEW

    STEAD KIERSTEN

    BOGUE ZACHARY

    • 10% Owner
    		 0 2020-12-11 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HANSEN CARL L. G. - Director - Officer - > 10% Owner CHIEF EXECUTIVE OFFICER

    		2023-11-27 16:45:10 -0500 2023-11-23 M 56,125 $2.70 a 673,500 direct 1.0571 1.0571 2 0.0 1

    HANSEN CARL L. G. - Director - Officer - > 10% Owner CHIEF EXECUTIVE OFFICER

    		2023-11-27 16:45:10 -0500 2023-11-23 M 56,125 d 6,389,191 direct

    MONTALBANO JOHN S. - Director

    		2023-11-08 15:29:53 -0500 2023-11-08 P 10,000 $4.46 a 86,000 direct -3.3493 8.3732 8.3732 6 -4.7847 4

    MONTALBANO JOHN S. - Director

    		2023-11-08 15:29:53 -0500 2023-11-06 P 20,000 $4.64 a 76,000 direct -3.3493 8.3732 8.3732 6 -4.7847 4

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 19:45:03 UTC 4.5288 0.7912 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 19:15:04 UTC 4.5276 0.7924 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 18:45:04 UTC 4.5276 0.7924 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 18:15:04 UTC 4.5276 0.7924 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 17:45:04 UTC 4.5276 0.7924 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 17:15:04 UTC 4.5276 0.7924 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 16:45:03 UTC 4.5309 0.7891 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 16:15:04 UTC 4.5309 0.7891 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 15:45:04 UTC 4.5309 0.7891 1300000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 15:15:04 UTC 4.5309 0.7891 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 14:45:04 UTC 4.5931 0.7269 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 14:15:04 UTC 4.5931 0.7269 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 13:45:04 UTC 4.5532 0.7668 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 13:15:04 UTC 4.5532 0.7668 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-30 12:45:03 UTC 4.5532 0.7668 1100000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-29 22:15:05 UTC 4.5322 0.7878 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-29 21:45:04 UTC 4.5322 0.7878 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-29 21:15:05 UTC 4.5322 0.7878 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-29 20:45:04 UTC 4.5322 0.7878 1200000
    ABCELLERA BIOLOGICS INC ABCL 2023-11-29 20:15:03 UTC 4.5305 0.7895 1200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments